Journal profile · ONCOLOGY-CELL BIOLOGY
CELLULAR ONCOLOGY
ISSN 2211-3428 · eISSN 2211-3436 · Springer Netherlands · NETHERLANDS · 6 issues per year · Founded 2011
CELLULAR ONCOLOGY: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 5.59; fully open access; APC about USD 4,390; median 104 days to acceptance (44 articles, last 24 months); community-reported acceptance: about 25%; 105 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
CELLULAR ONCOLOGY is published by Springer Netherlands and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer Cells and Metastasis, Cancer, Hypoxia, and Metabolism and Ferroptosis and cancer prognosis, together about 25.9% of its articles. Its main subfields are Oncology and Cancer Research. (generated from OpenAlex topic counts and CAS ranking data)
Cellular Oncology publishes scientific contributions from various biomedical and clinical disciplines involved in basic and translational cancer research on the cell and tissue level, technical and bioinformatics developments in this area, and clinical applications. This includes a variety of fields like genome technology, micro-arrays and other high-throughput techniques, genomic instability, SNP, DNA methylation, signaling pathways, DNA organization, (sub)microscopic imaging, proteomics, bioinformatics, functional effects of genomics, drug design and development, molecular diagnostics and targeted cancer therapies, genotype-phenotype interactions. A major goal is to translate the latest developments in these fields from the research laboratory into routine patient management. Cellular Oncology forms a platform of scientific information exchange between molecular biologists and geneticists, technical developers, pathologists, (medical) oncologists and other clinicians involved in the management of cancer patients. Cellular Oncology publishes Original Articles, Reviews, Short Communications, Commentaries, and Letters to the Editor.
From the journal's Aims & Scope
Research area (LetPub): ONCOLOGY-CELL BIOLOGY
Editor-in-chief Xiaohang QiaoPublisher website
Editorial board by country: 19 in mainland China (about 32%); most named Mainland China 19, Netherlands 14, United States 8, Germany 5, United Kingdom 2 (60 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer Cells and MetastasisMedicine10.9%
- Cancer, Hypoxia, and MetabolismBiochemistry, Genetics and Molecular Biology7.5%
- Ferroptosis and cancer prognosisMedicine7.5%
- Cancer Immunotherapy and BiomarkersMedicine7.2%
- Immune cells in cancerImmunology and Microbiology6.9%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology5%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology4.8%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology4.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 2 |
| Minor | Pathology | Zone 2 |
| Minor | Cell Biology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 3 |
| Minor | Cell Biology | Zone 3 |
| Minor | Pathology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Cell Biology | Zone 2 |
| Minor | Pathology | Zone 2 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.59LetPub ·
- Impact factor (publisher) 2024
- 4.8Publisher website ·
- 5-year impact factor (publisher) 2024
- 5.4Publisher website ·
- CiteScore 2026-06
- 8.6LetPub ·
- SJR 2026-06
- 1.56LetPub ·
- SNIP 2026-06
- 1LetPub ·
- h-index
- 31LetPub ·
- h-index
- 76OpenAlex ·
- i10-index
- 782OpenAlex ·
- 2-year mean citedness
- 4.31OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 51.69%LetPub ·
Volume
- Articles per year
- 98LetPub ·
- Downloads per year (publisher) 2025
- 669,100Publisher website ·
Articles by year OpenAlex count · 1,329 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 161 | 161 | 119 |
| 2025 | 105 | 105 | 456 |
| 2024 | 124 | 124 | 1,105 |
| 2023 | 147 | 147 | 2,501 |
| 2022 | 111 | 111 | 2,264 |
| 2021 | 76 | 76 | 2,671 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
104 daysMedian, submission to acceptance · P25–P75 82 days – 136 days
- Acceptance to online
- median 15 days (82 articles)
- Submission to online
- median 130 days
- Sample
- 44 articles with submission and acceptance dates (110 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 12 monthsLetPub ·
- Average acceptance (community reports)
- 25%LetPub ·
- Submission to first decision
- 6 daysPublisher website ·
- Peer review
- Single anonymous peer review, Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,390 / EUR 3,390 / GBP 2,790 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers2, by deadline
Publisher websiteWhat to prepare2 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
Article types accepted5, with length limits
- brief reportResearch There are no restrictions regarding the length of the text or the number of figures. Research articles should be formatted according to the guidelines …main text ≤ 1,000 words · figures and tables ≤ 2
- commentaryResearch There are no restrictions regarding the length of the text or the number of figures. Research articles should be formatted according to the guidelines …main text ≤ 1,500 words
- correspondenceResearch There are no restrictions regarding the length of the text or the number of figures. Research articles should be formatted according to the guidelines …main text ≤ 1,000 words · references ≤ 5
- research articleResearch There are no restrictions regarding the length of the text or the number of figures. Research articles should be formatted according to the guidelines …Length not stated
- reviewResearch There are no restrictions regarding the length of the text or the number of figures. Research articles should be formatted according to the guidelines …Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Cellular Oncology, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review Single-blind peer review
This journal follows a single-blind reviewing procedure. This journal also publishes special/guest-edited issues. The peer review process for these articles is the same as the peer review process of the journal in general. Additionally, if a guest editor authors an article in their issue/collection, they will not handle the peer review process. Back to top
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Netherlands
- Country or region
- NETHERLANDS
- Language
- English
- Frequency
- 6 issues per year
- Founded
- 2011
- ISSN
- 2211-3428
- Electronic ISSN
- 2211-3436
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about CELLULAR ONCOLOGY
What CAS zone is CELLULAR ONCOLOGY in?
In the 2025 upgraded edition of the CAS Journal Ranking, CELLULAR ONCOLOGY is in Zone 2 of Medicine, and in Zone 2 of the minor category Oncology / Pathology / Cell Biology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of CELLULAR ONCOLOGY?
The latest impact factor listed by LetPub is 5.59; CiteScore 8.6, h-index 76.
How long does peer review take at CELLULAR ONCOLOGY?
Based on the dates recorded on 44 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 104 days (interquartile range 82–136 days); authors report an average review time of about 12 months; the community-reported acceptance is “about 25%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of CELLULAR ONCOLOGY?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of CELLULAR ONCOLOGY based?
Of the 60 board members whose country the journal's board page names, 19 (about 32%) are in mainland China; the countries named most often are Mainland China (19), Netherlands (14) and United States (8). Counted from the institutions listed on the board page; for reference only.
Which databases index CELLULAR ONCOLOGY?
According to LetPub and DOAJ records, CELLULAR ONCOLOGY is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, Embase, CAS and Current Contents; that list has not been checked against each database.
Is CELLULAR ONCOLOGY open access, and what is the APC?
CELLULAR ONCOLOGY is a fully open-access journal. APC about USD 4,390.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .